Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2025-12-24 @ 11:42 PM
NCT ID:
NCT00140751
Eligibility Criteria:
Inclusion Criteria:
* Age \> or = 18 years
* Confirmed HIV-1 seropositivity
* Antiretroviral treatment stable since 3 months at least
* HIV-1 ARN load \< 50 copies/mL since 6 months at least
* Signed consent form
* No history of treatment failure (= viral load \> 1000 copies/mL) including a protease inhibitor
* No opportunistic infection in the previous 6 months
Exclusion Criteria:
* Neutrophils \< 750/mm3
* Hemoglobin \< 8 g/dL
* Platelets \< 60,000/mm3
* Creatinin \> 150 micromoles/L
* SGOT \> 5 NUL (Normal Upper Limit)
* SGPT \> 5 NUL
* Current IL-2 treatment
* HBV infection treated or not by lamivudine or tenofovir
* Pregnancy or feeding
* Enrollment in another study not compliant with KALESOLO Study group assignment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00140751
Study Brief:
Protocol Section:
NCT00140751